Patrizia Cavazzoni MD

Artificial Intelligence May 26, 2023

FDA Spurs Conversation about AI and ML in Drug Development and Manufacturing

By Patrizia Cavazzoni MD – AI and ML are no longer futuristic concepts; they are now part of how we live and work. The FDA uses the term AI to describe a branch of computer science, statistics, and engineering that uses algorithms or models to perform tasks and exhibit behaviors.

COVID-19 July 17, 2020

An Update and Behind the Scenes: FDA’s Coronavirus Treatment Acceleration Program

By Stephen M. Hahn MD, Patrizia Cavazzoni MD, & Peter Marks MD, PhD – When the U.S. Food and Drug Administration learned of the novel coronavirus (COVID-19) and its potentially devastating effects, we acted swiftly to set the regulatory stage for drug and biologics manufacturers to develop products to treat this serious disease.